Mika Morita
Kansai Medical University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mika Morita.
Digestive Diseases and Sciences | 2007
Masaki Kaibori; Mika Morita; Shuuji Tagami; Yoichiro Uchida; Hironori Tanaka; Kazuhiko Yoshioka; Yu Takahashi; Noriko Sakaida; Yoshiko Uemura; Toshihito Seki; Kazuichi Okazaki; Yasuo Kamiyama
Hepatocellular carcinoma (HCC) is a common malignancy that is responsible for more than 250,000 deaths worldwide each year [1]. HCC frequently metastasizes to extrahepatic organs, such as the lungs, bones, and brain, whereas metastasis to the skin or gastrointestinal tract is uncommon [2]. Cutaneous seeding of tumor cells along the abdominal drain track or within the surgical wound has been reported after resection of different types of abdominal tumors [3–6], while metastasis of HCC to the gastrointestinal tract usually involves direct infiltration of the stomach or large bowel [7, 8]. Occurrence of both cutaneous and colonic metastases in the same patient after resection of HCC has not been described previously to our knowledge. In this article we report the case of a patient with cutaneous and colonic metastases after surgical resection of HCC.
Archive | 1993
Kanji Tanaka; Mika Morita; Shigeo Okamura; Tokio Okusa; Yasushi Nakane; Hideho Takada; Koshirou Hioki
60 cases of colorectal adenocarcinoma were immunohistochemically examined to clarify the relationship between HLA - DR expression on tumor cells and T cell infiltration. The more HLA-DR+ cancer cells in the carcinoma tissue increased, the more T cells tended to aggregate in both the infiltrating front of cancer tissue and the intracarcinomatuos stroma. We speculate that HLA - DR antigen on cancer cells might be immunoreactive and seems to be closely related with the cellular immunity in colorectal carcinoma.
Archive | 1993
Kanji Tanaka; Mika Morita; Takayuki Motohiro; Hideharu Yamanaka; Yasushi Nakane; Koshirou Hioki
The major histocompatibility complex (MHC) class II antigen HLA-DR is known to be present on many types of immunocompetent cells, involved in a variety of immune functions, and can be found in various kinds of cancer cells of the gastrointestinal tract. It is also reported that HLA-DR is associated with tumor invasion, tumor metastasis, and patient survival [1].
Journal of Surgical Oncology | 1995
Mika Morita; Kanji Tanaka; Hiroshi Kawanishi; Masazumi Tsuji; Tokio Ookusa; Hideho Takada; Akiharu Okamura; Koshiro Hioki
Nippon Daicho Komonbyo Gakkai Zasshi | 1992
Kazuhiko Yoshioka; Mika Morita; Hideho Takada; K. Hioki
Nippon Daicho Komonbyo Gakkai Zasshi | 2006
Mika Morita; Kazuhiko Yoshioka; Yoshitaka Hata; M. Nakano; Shigeyoshi Iwamoto; Yasuhiro Yonekura; Yasushi Nakane
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 2005
Mika Morita; M. Nakano; Yasuhiro Yonekura; Shigeyoshi Iwamoto; Kazuhiko Yoshioka; Yasushi Nakane
Nippon Daicho Komonbyo Gakkai Zasshi | 2004
Y. Hata; Shigeyoshi Iwamoto; Yasuhiro Yonekura; Mika Morita; Kazuhiko Yoshioka; Noriko Sakaida
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 1995
Ryo Yoshida; Yoshinori Hamada; Homa Oota; Hitoshi Iiyama; Taketo Sawaguchi; Takashi Mouri; Mika Morita; Tsunehide Boku; Kanji Tanaka; Hideho Takada; K. Hioki
Nihon Rinsho Geka Gakkai Zasshi (journal of Japan Surgical Association) | 1994
Mika Morita; Kanji Tanaka; Koshirou Hioki